SCHEMBL22001148

SCHEMBL22001148

Cc1ccc(N(c2ccccc2)c2cccc(Cl)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3E A5X5Y0 1/20 0.42
▸ HTR3B O95264 1/20 0.42
▸ HTR3A P46098 1/20 0.42
▸ HTR3D Q70Z44 1/20 0.42
▸ HTR3C Q8WXA8 1/20 0.42
▸ MAPT P10636 2/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HCRTR2 O43614 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.39
▸ PGR P06401 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16318397 0.96 HTR3E (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL1816509 0.95 MAPT (0.40) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL1812550 0.95 MAPT (0.40) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL9581152 0.91 HTR3E (0.41) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL8100812 0.90 MAPT (0.48) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL9480211 0.89 HPGD (0.53) MAPTALDH1A1TDP1L3MBTL1PGR
SCHEMBL9321690 0.88 MAPT (0.50) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL25853285 0.87 KMT2A (0.46) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL22336635 0.87 ALDH1A1 (0.42) MAPTALDH1A1CYP2C19KDM4ECYP1A2
SCHEMBL1813437 0.86 MEN1 (0.43) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200152874-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2020-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200152874-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF OR10J3, OR51E2, PIEZO1 HTR3E 4634/4885HTR3B 4806/4885HTR3A 4838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback